Search results
Results from the WOW.Com Content Network
Trump said during a rally in late October that he would let Kennedy “go wild” on healthcare in the country, and vaccine stocks like Moderna and Novavax have been heading lower since. Thursday ...
An hour before the market closed Thursday, as news reports of Trump’s choice began trickling out, Covid-19 vaccine maker Moderna dipped as much as 6%, and Pfizer fell almost 2%.
The news, which came late in the day on Thursday, sent the shares of vaccine-makers sharply lower on Friday, with Moderna leading the losses, falling as much as 10%. Pfizer and Novavax both ...
Unlike the COVID-19 pandemic, when the U.S. government subsidized private companies to make the COVID-19 vaccine, the government actually has a stockpile of H5N1 virus candidates that could be ...
Stocks of coronavirus vaccine could run out at the end of January unless new ones such as the Oxford jab are approved, a former minister has warned. Former health secretary Jeremy Hunt told the ...
(Reuters) -Pfizer set off a fresh round of concern about the size of the U.S. COVID-19 vaccine and treatment market in the long term, driving down shares on Monday of its German partner BioNTech ...
For premium support please call: 800-290-4726 more ways to reach us
As people acclimatize to the new normal, it’s time to look at some vaccine stocks to sell. Instead of relying primarily on vaccines and antiviral drugs, the government let people manage infections.